@ERSpublicationsWe should see telemedicine as an adjunct to self-management approaches, assisting proper healthcare coaching and helping patients to be more adherent in problem solving, decision making and acting earlier in the course of COPD exacerbations http://ow.ly/UNv530k2LcYCite this article as: Bourbeau J, Farias R. Making sense of telemedicine in the management of COPD. Eur Respir J 2018; 51: 1800851 [https://doi.org/10.1183/13993003.00851-2018.Exacerbations of chronic obstructive pulmonary disease (COPD) are important events with negative impact on health status, hospitalisations and readmissions, and disease progression [1]. Treatments aim at reducing the risk of exacerbations and complications such as hospital admissions. Although treatment strategies to prevent COPD exacerbations and their subsequent hospital admissions are still largely based on pharmacological therapies, the Global Initiative for Chronic Obstructive Lung Disease 2017 also recommended non-pharmacological treatment, such as self-management interventions with communication with a healthcare professional [2]. The most recent Cochrane review reported that self-management interventions that include written action plans and coaching with a healthcare professional for a prompt treatment of worsening symptoms lead to a lower probability of both respiratory-related and all-cause hospitalisations, and also improve health status [3]. There remain problems with heterogeneity among interventions and consistency in their application that make generalisation difficult in real life. In light of these challenges, there has been increased interest in health information technology to ease the working life of health practitioners and to transform the way healthcare is delivered. There have been big promises made for the use of health information technology, with the rapid development of information and communication technologies for the management of chronic diseases. However, these promises may not have been realised in terms of tracking COPD patients for earlier detection of disease exacerbations and early intervention to minimise the deterioration that so frequently results in the need for hospitalisations [4,5].In PROMETE II, a multicentre, randomised, 12-month trial described by ANCOCHEA et al. [6] in this issue of the European Respiratory Journal, a specific telemedicine system was compared with routine clinical practice in patients with severe COPD. The system includes a remote patient-monitoring platform with equipment provided for blood pressure, oxygen saturation, heart rate and spirometry measurement, which were actively measured by the patient at home as per instructions, while respiratory rate and oxygen adherence data were passively collected by a device connected to the oxygen feed from their main oxygen source. Patients took measurements at the same time each day, at rest and after having taken their prescribed medication and with the oxygen therapy. The information was received by the monitoring centre, which used a triage application ...